Skip to main content
. 2021 Sep 8;16(9):e0256308. doi: 10.1371/journal.pone.0256308

Table 2. Correlation of demographic and risk factors in VAP and Non-VAP patients by univariate analysis.

SN Variable Total cases (n = 244) Non-VAP (n = 57) VAP (n = 187) Chi-square
1. Mean age±SD (Range) 46.85± 18.13 (19–89) 49.25±17.93 (19–82) 46.08±18.18 (19–89) 1.132 0.259
n % n % χ2 p
2. Age (Years)
18–25 35 7 12.7 28 16.3 2.101 0.717
26–40 60 12 21.8 48 27.9
41–60 75 20 36.4 55 32.0
61–80 51 15 27.3 36 20.9
>80 6 1 1.8 5 2.9
3. Sex
Females 79 26 47.3 53 30.8 4.975 0.026
Male 148 29 52.7 119 69.2
4. Smoking 86 17 30.9 69 40.1 1.501 0.220
5. Alcohol 41 9 16.4 32 18.6 0.141 0.707
6. Diabetes 30 7 12.7 23 13.4 0.015 0.902
7. Hypertension 81 18 32.7 63 36.6 0.276 0.599
8. Liver disease 18 6 10.9 12 7.0 0.883 0.347
9. Lung disease 39 7 12.7 32 18.6 1.012 0.314
10. Renal disease 22 8 14.5 14 8.1 1.954 0.162
11. Neurological 11 2 3.6 9 5.2 0.230 0.631
12. Surgery 109 18 32.7 91 52.9 6.799 0.009
13. Tracheostomy 68 13 23.6 55 32.0 1.382 0.240
14. Heart disease 13 6 10.9 7 4.1 3.611 0.057
15. CPIa Score ≥6 186 15 27.3 171 99.4 146.569 <0.001
16. Previous Antibiotic history 62 12 6.7 50 29.1 30.421 <0.001

aCPI score- Clinical pulmonary infection Score.